Phreesia, Inc. (PHR) |
| 16.58 -0.56 (-3.27%) 01-13 16:00 |
| Open: | 17.09 |
| High: | 17.17 |
| Low: | 16.2994 |
| Volume: | 918,867 |
| Market Cap: | 1,000(M) |
| PE Ratio: | -184.22 |
| Exchange: | New York Stock Exchange |
| Industry: | Medical - Healthcare Information Services |
| Sector: | Healthcare |
| Technical analysis | ||||
![]() |
||||
| sell | buy | |||
| Resistance 2: | 21.24 |
| Resistance 1: | 19.01 |
| Pivot price: | 16.94 |
| Support 1: | 15.41 |
| Support 2: | 12.82 |
| 52w High: | 32.76 |
| 52w Low: | 15.41 |
Phreesia, Inc. provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. Its Phreesia Platform offers a suite of solutions to manage the patient intake process, as well as an integrated payments solution for processing of patient payments. The company deploys its platform in a range of modalities, such as Phreesia Mobile, a patients' mobile device; Phreesia Dashboard, a web-based dashboard for healthcare services clients; PhreesiaPads, which are self-service intake tablets; and Arrivals Kiosks that are on-site kiosks. Its Phreesia Platform also provides a registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, and cost estimation tools; access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking; and life sciences solution to deliver targeted and clinically relevant marketing content to patients. In addition, the company's Phreesia Platform offers clinical support solution, which collects clinical intake and patient reported outcome (PRO) data for approximately 25 specialties, as well as enables healthcare services clients to communicate with their patients through surveys, announcements, text and email messaging, and health campaigns; and COVID-19 support modules for managing COVID-19 vaccine delivery and identify vaccine-hesitant patients, screening for self-reported COVID-19 risk factors, enabling contactless check-in during in-person visits, and collecting intake information during telehealth visits. It serves patients; single-specialty practices, multi-specialty groups, and health systems; and pharmaceutical, medical device, and biotechnology companies. The company was incorporated in 2005 and is headquartered in Raleigh, North Carolina.
| EPS | -0.090 |
| Book Value | 5.320 |
| PEG Ratio | 0.00 |
| Gross Profit | 5.240 |
| Profit Margin (%) | -1.16 |
| Operating Margin (%) | -46.68 |
| Return on Assets (ttm) | -0.3 |
| Return on Equity (ttm) | -1.9 |
Fri, 09 Jan 2026
Wells Fargo Initiates Coverage on Phreesia (PHR) with Overweight Rating | PHR Stock News - GuruFocus
Tue, 30 Dec 2025
Phreesia, Inc. (PHR) Investor Outlook: 75% Upside Potential According to Analyst Consensus - DirectorsTalk Interviews
Mon, 22 Dec 2025
Phreesia: Profitable At Last, Priced Like It Isn’t (NYSE:PHR) - Seeking Alpha
Thu, 18 Dec 2025
Phreesia Named to The Software Report’s “Top 50 Software Companies” for the Fourth Consecutive Year - Business Wire
Tue, 16 Dec 2025
Phreesia, Inc. (PHR) Stock Analysis: A Strong Buy With 78% Potential Upside - DirectorsTalk Interviews
Wed, 10 Dec 2025
Phreesia (PHR) Loses 32.2% in 4 Weeks, Here's Why a Trend Reversal May be Around the Corner - Nasdaq
|
StockChart iOS |
StoxlineLite iOS |
StoxlineLite iOS |
OptionCalc iOS |
|
StockChart Android |
StoxlineLite Android |
StoxlinePro Android |
OptionCalc Android |